Ignacio
Gil-Bazo
Ignacio Gil-Bazo-rekin lankidetzan egindako argitalpenak (9)
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2015
-
Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis
Journal of Translational Medicine, Vol. 13, Núm. 1
-
Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors
Minerva Chirurgica
2014
-
Epidermal growth factor receptor targeting in non-small cell lung cancer: Revisiting different strategies against the same target
Current Drug Targets, Vol. 15, Núm. 14, pp. 1273-1283
2013
-
Clinical management of small-cell carcinoma of the urinary tract: A 10-year single-center's experience
Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 168-174
-
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: A retrospective cohort study
Journal of Neuro-Oncology
-
Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer
Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 78-84